These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18625856)

  • 21. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.
    Ingelsson M; Fukumoto H; Newell KL; Growdon JH; Hedley-Whyte ET; Frosch MP; Albert MS; Hyman BT; Irizarry MC
    Neurology; 2004 Mar; 62(6):925-31. PubMed ID: 15037694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease.
    Liu H; Kim C; Haldiman T; Sigurdson CJ; Nyström S; Nilsson KPR; Cohen ML; Wisniewski T; Hammarström P; Safar JG
    J Biol Chem; 2021 Nov; 297(5):101267. PubMed ID: 34599965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
    Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
    JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
    Tekirian TL; Saido TC; Markesbery WR; Russell MJ; Wekstein DR; Patel E; Geddes JW
    J Neuropathol Exp Neurol; 1998 Jan; 57(1):76-94. PubMed ID: 9600199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients.
    Svedberg MM; Hall H; Hellström-Lindahl E; Estrada S; Guan Z; Nordberg A; Långström B
    Neurochem Int; 2009; 54(5-6):347-57. PubMed ID: 19162107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.
    Mc Donald JM; Savva GM; Brayne C; Welzel AT; Forster G; Shankar GM; Selkoe DJ; Ince PG; Walsh DM;
    Brain; 2010 May; 133(Pt 5):1328-41. PubMed ID: 20403962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
    Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
    Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
    Sevigny J; Chiao P; Bussière T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; O'Gorman J; Qian F; Arastu M; Li M; Chollate S; Brennan MS; Quintero-Monzon O; Scannevin RH; Arnold HM; Engber T; Rhodes K; Ferrero J; Hang Y; Mikulskis A; Grimm J; Hock C; Nitsch RM; Sandrock A
    Nature; 2016 Sep; 537(7618):50-6. PubMed ID: 27582220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
    Jimenez S; Navarro V; Moyano J; Sanchez-Mico M; Torres M; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    PLoS One; 2014; 9(12):e114041. PubMed ID: 25485545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model.
    Luo R; Su LY; Li G; Yang J; Liu Q; Yang LX; Zhang DF; Zhou H; Xu M; Fan Y; Li J; Yao YG
    Autophagy; 2020 Jan; 16(1):52-69. PubMed ID: 30898012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
    Näslund J; Haroutunian V; Mohs R; Davis KL; Davies P; Greengard P; Buxbaum JD
    JAMA; 2000 Mar 22-29; 283(12):1571-7. PubMed ID: 10735393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
    Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
    J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.
    McLean CA; Cherny RA; Fraser FW; Fuller SJ; Smith MJ; Beyreuther K; Bush AI; Masters CL
    Ann Neurol; 1999 Dec; 46(6):860-6. PubMed ID: 10589538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.